Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, disclosing a beneficial ownership of 15.8% of ARMOUR RESIDENTIAL REIT INC's common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 17.1% of California Water Service Group's common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 11.0% in Topgolf Callaway Brands Corp., totaling 20,274,023 common shares as of June 30, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting a 5.1% beneficial ownership stake in The Eastern Company's common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has reported a 2.1% beneficial ownership stake in Full House Resorts Inc., holding 759,625 common shares as of June 30, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, revealing a 6.0% beneficial ownership stake in Genie Energy Ltd.'s Class B Stock.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.7% in Genuine Parts Company as of June 30, 2025.
NYSE
BlackRock, Inc. has reported a beneficial ownership of 6.7% of GEVO INC's common stock, holding 16,004,547 shares as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 17 to its Schedule 13G, disclosing a 9.3% beneficial ownership stake in Interpublic Group of Companies Inc., totaling 34,509,287 shares.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 1.5% beneficial ownership stake in Jasper Therapeutics Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.9% passive beneficial ownership stake in KKR & Co. Inc.'s Class A Stock as of June 30, 2025.
NYSE
BlackRock, Inc. has increased its beneficial ownership in Medical Properties Trust Inc. to 13.1% of common stock, holding over 78 million shares.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 1.9% of Ocugen, Inc.'s common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.2% beneficial ownership stake in ORIC PHARMACEUTICALS INC as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 9.3% beneficial ownership stake in Prologis, Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has reported a 5.6% beneficial ownership stake in Ramaco Resources, Inc.'s Class A Stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 0.7% beneficial ownership stake in Ring Energy Inc. common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 16 to its Schedule 13G, disclosing a 15.9% beneficial ownership stake in Ryman Hospitality Properties Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 14.0% in Sabre Corp's common stock, totaling over 54 million shares.
NYSE
BlackRock, Inc. has reported a beneficial ownership of 5.0% of Sable Offshore Corp's Class A Stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.4% of Fox Corp's Class B Stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, reporting a beneficial ownership of 14.7% of Integer Holdings Corporation's common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a beneficial ownership of 14.6% in Pediatrix Medical Group, Inc.'s common stock.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 15.3% beneficial ownership stake in Myriad Genetics Inc., totaling 14,105,009 shares of common stock.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a reduction in its beneficial ownership of Navitas Semiconductor Corp. common stock to 4.97%.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.96% beneficial ownership stake in ORTHOPEDIATRICS CORP as of June 30, 2025, held for investment purposes.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, disclosing a 9.0% beneficial ownership stake in Ovintiv Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 15.7% beneficial ownership stake in Premier, Inc.'s Class A Stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, revealing a 5.6% beneficial ownership stake in Protara Therapeutics, Inc. as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 14.3% beneficial ownership stake in Safety Insurance Group Inc., totaling 2,134,011 common shares.